Audrey Ricard Campion joins Pierre Fabre Laboratories as Head of Research and Development Dermo-Cosmetics
20 June 2025
Toulouse, June 20, 2025 - Pierre Fabre Laboratories announces the appointment of Audrey Ricard Campion as Head of Research and Development for its Dermo-Cosmetics & Personal Care business. Reporting to Frédéric Ennabli, CEO of Pierre Fabre Dermo-Cosmetics, she will join the Executive Committee and will be responsible for defining and implementing the company’s innovation strategy.
An engineering graduate in physics and chemistry, Audrey Ricard Campion has acquired in-depth expertise in the science of skin over the course of her career. Her work, characterized by the encapsulation and vectorization of active ingredients and pigments, as well as the use of adhesive polymers, has given rise to numerous patents, particularly in the fields of photoprotection and facial skincare.
Audrey will now be putting her experience to work for Pierre Fabre Laboratories' Dermo-Cosmetics & Personal Care portfolio, which includes major international brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer and Elgydium.
Audrey Ricard Campion will be based at the Pierre Fabre Innovation Center, on the Oncopole campus in Toulouse. She will head up an organization of 420 employees based mainly in Toulouse, as well as in the innovation centers in Shanghai, specializing in Asian skin types, and Rio de Janeiro, specializing in skin types found in South America.
She will be able to draw on multidisciplinary expertise, including biology, clinical pharmacology, biotechnology and formulation, to support priority fields of research such as sun protection, acne treatment, atopy, skin repair and alopecia.
We are delighted to welcome Audrey Ricard Campion as our Head of Research & Development. Both creative and pragmatic, Audrey knows exactly how to combine her passion for fundamental research with her expertise in formulation to develop innovative products. Her vision and ability to investigate every detail will be decisive in the success of our medical mission: to release patients from skin pathologies, while helping them overcome the associated psychological and social aspects
I’m thrilled to be joining Pierre Fabre Laboratories and contribute to this new vision of therapeutic dermo-cosmetics, which resonates deeply with my values.
It’s an exceptional opportunity to lead research projects inspired by therapeutic advances and drug mechanisms of action, to offer innovative dermo-cosmetic skincare products. I look forward to working with passionate researchers to develop skin care products with high added therapeutic value adapted to all dermatological needs
About Pierre Fabre Laboratories
Pierre Fabre Laboratories is the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical laboratories. Its Dermo-cosmetics & Personal Care portfolio includes international brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Même Cosmetics, Darrow and Elgydium. Its Medical Care activity covers 5 main therapeutic fields: oncology, dermatology, rare diseases primary care and family health care.
In 2024, Pierre Fabre Laboratories posted 3.1 billion euros in revenues, 71% of which came from international sales in 120 countries. Based in southwest France since its creation and manufacturing more than 90% of its products in France, Pierre Fabre Laboratories employs 10,200 people worldwide. Its R&D budget amounted to 219 million euros in 2024, of which 60% was allocated to targeted therapies in oncology and 35% to skin health and care solutions.
Pierre Fabre Laboratories’ majority shareholder (86%) is an eponymous Foundation, which is recognized by the French government as being a public-interest foundation. Employees constitute the company’s other shareholder. This capital structure guarantees the company’s independence, long-term vision and contribution to the common good. The dividends paid to the Pierre Fabre Foundation contribute to 35 healthcare-access programs deployed in 22 of the least developed countries in the world.
Pierre Fabre Laboratories’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development).
For more information, visit www.pierre-fabre.com, @Laboratoires Pierre Fabre, @Pierre Fabre Oncology